Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Hargreaves, RJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Williamson, DJ; Hargreaves, RJ
      Neurogenic inflammation in the context of migraine

      MICROSCOPY RESEARCH AND TECHNIQUE
    2. Harrison, T; Owens, AP; Williams, BJ; Swain, CJ; Williams, A; Carlson, EJ; Rycroft, W; Tattersall, FD; Cascieri, MA; Chicchi, GG; Sadowski, S; Rupniak, NMJ; Hargreaves, RJ
      An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration

      JOURNAL OF MEDICINAL CHEMISTRY
    3. Williamson, DJ; Hill, RG; Shepheard, SL; Hargreaves, RJ
      The anti-migraine 5-HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs

      BRITISH JOURNAL OF PHARMACOLOGY
    4. Williamson, DJ; Shepheard, SL; Cook, DA; Hargreaves, RJ; Hill, RG; Cumberbatch, MJ
      Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats

      BRITISH JOURNAL OF PHARMACOLOGY
    5. Silberstein, SD; Hargreaves, RJ
      The history and pharmacology of ergotamine and dihydroergotamine

      DRUG TREATMENT OF MIGRAINE AND OTHER HEADACHES
    6. Hargreaves, RJ; Longmore, J; Beer, M; Shepheard, S; Cumberbatch, M; Williamson, D; Stanton, J; Razzaque, Z; Sohal, B; Street, L; Seabrook, G; Hill, R
      The pharmacology and mechanisms of action of rizatriptan

      DRUG TREATMENT OF MIGRAINE AND OTHER HEADACHES
    7. Hargreaves, RJ
      Pharmacology and potential mechanisms of action of rizatriptan

      CEPHALALGIA
    8. Ma, QP; Hargreaves, RJ
      Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats

      NEUROSCIENCE
    9. Tattersall, FD; Rycroft, W; Cumberbatch, M; Mason, G; Tye, S; Williamson, DJ; Hale, JJ; Mills, SG; Finke, PE; MacCoss, M; Sadowski, S; Ber, E; Cascieri, M; Hill, RG; MacIntyre, DE; Hargreaves, RJ
      The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L758,298, inhibit acute and delayed cisplatin-inducedemesis in ferrets

      NEUROPHARMACOLOGY
    10. Goadsby, PJ; Hargreaves, RJ
      Mechanisms of action of serotonin 5-HT1B/1D agonists: Insights into migraine pathophysiology using rizatriptan

      NEUROLOGY
    11. Hargreaves, RJ; Shepheard, SL
      Pathophysiology of migraine - New insights

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    12. Cumberbatch, MJ; Williamson, DJ; Mason, GS; Hill, RG; Hargreaves, RJ
      Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist

      BRITISH JOURNAL OF PHARMACOLOGY
    13. Dahlof, CGH; Hargreaves, RJ
      Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies?

      CEPHALALGIA
    14. Cumberbatch, MJ; Hill, RG; Hargreaves, RJ
      Differential effects of the 5HT(1B/1D) receptor agonist naratriptan on trigeminal versus spinal nociceptive responses

      CEPHALALGIA
    15. KRAMER MS; CUTLER N; FEIGHNER J; SHRIVASTAVA R; CARMAN J; SRAMEK JJ; REINES SA; LIU GH; SNAVELY D; WYATTKNOWLES E; HALE JJ; MILLS SG; MACCOSS M; SWAIN CJ; HARRISON T; HILL RG; HEFTI F; SCOLNICK EM; CASCIERI MA; CHICCHI GG; SADOWSKI S; WILLIAMS AR; HEWSON L; SMITH D; CARLSON EJ; HARGREAVES RJ; RUPNIAK NMJ
      DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS

      Science
    16. WILLIAMSON DJ; CUMBERBATCH MJ; SHEPHEARD SL; HARGREAVES RJ
      SENSITIZATION OF CAUDAL TRIGEMINAL NEURONS BY DURAL ARTERY DILATATION

      Neurology
    17. Cumberbatch, MJ; Hill, RG; Hargreaves, RJ
      The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. MAY A; SHEPHEARD SL; KNORR M; EFFERT R; WESSING A; HARGREAVES RJ; GOADSBY PJ; DIENER HC
      RETINAL PLASMA EXTRAVASATION IN ANIMALS BUT NOT IN HUMANS - IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF MIGRAINE

      Brain (Print)
    19. WILLIAMSON DJ; HARGREAVES RJ; HILL RG; SHEPHEARD SL
      INTRAVITAL MICROSCOPE STUDIES ON THE EFFECTS OF NEUROKININ AGONISTS AND CALCITONIN-GENE-RELATED PEPTIDE ON DURAL VESSEL DIAMETER IN THE ANESTHETIZED RAT

      Cephalalgia
    20. WILLIAMSON DJ; HARGREAVES RJ; HILL RG; SHEPHEARD SL
      SUMATRIPTAN INHIBITS NEUROGENIC VASODILATION OF DURAL BLOOD-VESSELS IN THE ANESTHETIZED RAT - INTRAVITAL MICROSCOPE STUDIES

      Cephalalgia
    21. SHEPHERD SL; WILLIAMSON DJ; BEER MS; HILL RG; HARGREAVES RJ
      DIFFERENTIAL-EFFECTS OF 5-HT1B 1D RECEPTOR AGONISTS ON NEUROGENIC DURAL PLASMA EXTRAVASATION AND VASODILATION IN ANESTHETIZED RATS/

      Neuropharmacology
    22. LONGMORE J; RAZZAQUE Z; SCHOFIELD WN; TAYLOR AA; BROWN MJ; PICKARD J; HILL RG; HARGREAVES RJ
      RIZATRIPTAN SHOWS CRANIOVASCULAR SELECTIVITY FOR HUMAN ISOLATED MIDDLE MENINGEAL OVER CORONARY-ARTERIES - A COMPARISON WITH SUMATRIPTAN

      Neurology
    23. HARGREAVES RJ; WILLIAMSON DJ; HILL RG; SHEPHEARD SL
      RIZATRIPTAN INHIBITS NEUROGENIC DURAL VASODILATION - AN INTRAVITAL MICROSCOPE STUDY IN RATS

      Neurology
    24. CUMBERBATCH MJ; MASON GS; HILL RG; HARGREAVES RJ
      TRIGEMINAL NEURONS THAT RECEIVE NONNOCICEPTIVE VIBRISSAL INPUT IN THEANESTHETIZED RAT - EFFECTS OF CONVERGENT NOCICEPTIVE INPUT FROM THE DURA-MATER AND OF A 5-HT1B 1D AGONIST/

      Journal of physiology
    25. CUMBERBATCH MJ; HILL RG; HARGREAVES RJ
      RIZATRIPTAN HAS CENTRAL ANTINOCICEPTIVE EFFECTS AGAINST DURALLY EVOKED-RESPONSES

      European journal of pharmacology
    26. WILLIAMSON DJ; SHEPHEARD SL; HILL RG; HARGREAVES RJ
      THE NOVEL ANTIMIGRAINE AGENT RIZATRIPTAN INHIBITS NEUROGENIC DURAL VASODILATION AND EXTRAVASATION

      European journal of pharmacology
    27. RUPNIAK NMJ; TATTERSALL FD; WILLIAMS AR; RYCROFT W; CARLSON EJ; CASCIERI MA; SADOWSKI S; BER E; HALE JJ; MILLS SG; MACCOSS M; SEWARD E; HUSCROFT I; OWEN S; SWAIN CJ; HILL RG; HARGREAVES RJ
      IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS

      European journal of pharmacology
    28. LONGMORE J; HILL RG; HARGREAVES RJ
      NEUROKININ-RECEPTOR ANTAGONISTS - PHARMACOLOGICAL TOOLS AND THERAPEUTIC DRUGS

      Canadian journal of physiology and pharmacology
    29. CUMBERBATCH MJ; HILL RG; HARGREAVES RJ
      RIZATRIPTAN INHIBITS TRIGEMINAL NOCICEPTIVE RESPONSES IN AN ELECTROPHYSIOLOGICAL ASSAY IN THE ANESTHETIZED RAT

      British Journal of Pharmacology
    30. RUPNIAK NMJ; TATTERSALL FD; WILLIAMS AR; RYCROFT W; CARLSON EJ; CASCIERI MA; HALE JJ; MILLS SG; MACCOSS M; SEWARD E; HUSCROFT I; SWAIN CJ; HILL RG; HARGREAVES RJ
      PREDICTION OF THE ANTIEMETIC ACTIVITY OF NK1 RECEPTOR ANTAGONISTS IN FERRETS BY THEIR ABILITY TO INHIBIT GR73632-INDUCED FOOT TAPPING IN GERBILS

      British Journal of Pharmacology
    31. STERNFELD F; BAKER R; BROUGHTON HB; GUIBLIN AR; JELLEY RA; MATASSA VG; REEVE AJ; BEER MS; STANTON JA; HARGREAVES RJ; SHEPHEARD SL; LONGMORE J; RAZZAQUE Z; GRAHAM MI; SOHAL B; STREET LJ
      THE CHEMICAL EVOLUTION OF 2-[5-(1,2,4-TRIAZOL-4-YL)-1H-INDOL-3-YL]ETHYLAMINE (L-741,604) AND ANALOGS - POTENT AND SELECTIVE AGONISTS FOR 5-HT1D RECEPTORS

      Bioorganic & medicinal chemistry letters
    32. TATTERSALL FD; RYCROFT W; FRANCIS B; PEARCE D; MERCHANT K; MACLEOD AM; LADDUWAHETTY T; KEOWN L; SWAIN C; BAKER R; CASCIERI M; BER E; METZGER J; MACINTYRE DE; HILL RG; HARGREAVES RJ
      TACHYKININ NK1 RECEPTOR ANTAGONISTS ACT CENTRALLY TO INHIBIT EMESIS INDUCED BY THE CHEMOTHERAPEUTIC AGENT CISPLATIN IN FERRETS

      Neuropharmacology
    33. LADDUWAHETTY T; BAKER R; CASCIERI MA; CHAMBERS MS; HAWORTH K; KEOWN LE; MACINTYRE DE; METZGER JM; OWEN S; RYCROFT W; SADOWSKI S; SEWARD EM; SHEPHEARD SL; SWAIN CJ; TATTERSALL FD; WATT AP; WILLIAMSON DW; HARGREAVES RJ
      N-HETEROARYL-2-PHENYL-3-(BENZYLOXY)PIPERIDINES - A NOVEL CLASS OF POTENT ORALLY-ACTIVE HUMAN NK1 ANTAGONISTS

      Journal of medicinal chemistry
    34. SEABROOK GR; SHEPHEARD SL; WILLIAMSON DJ; TYRER P; RIGBY M; CASCIERI MA; HARRISON T; HARGREAVES RJ; HILL RG
      L-733,060, A NOVEL TACHYKININ NK1 RECEPTOR ANTAGONIST - EFFECTS IN [CA2+](I) MOBILIZATION, CARDIOVASCULAR AND DURAL EXTRAVASATION ASSAYS

      European journal of pharmacology
    35. LAIRD JMA; MASON GS; WEBB J; HILL RG; HARGREAVES RJ
      EFFECTS OF A PARTIAL AGONIST AND A FULL ANTAGONIST ACTING AT THE GLYCINE SITE OF THE NMDA RECEPTOR ON INFLAMMATION-INDUCED MECHANICAL HYPERALGESIA IN RATS

      British Journal of Pharmacology
    36. MASON GS; TATTERSALL FD; HILL RG; HARGREAVES RJ
      EFFECT OF THE NK1 RECEPTOR ANTAGONISTS, L-733,060 AND CP-99,994, AND MORPHINE IN THE RABBIT SPINAL REFLEX PREPARATION

      British Journal of Pharmacology
    37. SHEPHEARD SL; WILLIAMSON DJ; COOK D; HILL RG; HARGREAVES RJ
      STUDIES ON THE SYMPATHOLYTIC EFFECTS OF SOME 5-HT1D RECEPTOR AGONISTSIN PITHED RATS AND GUINEA-PIGS

      British Journal of Pharmacology
    38. WILLIAMSON DJ; HARGREAVES RJ; HILL RG; SHEPHEARD SL
      DIRECT MEASUREMENT OF DURAL BLOOD-VESSEL DIAMETER IN THE RAT USING INTRAVITAL MICROSCOPY

      British Journal of Pharmacology
    39. LAIRD JMA; MASON GS; THOMAS KA; HARGREAVES RJ; HILL RG
      ACIDIC FIBROBLAST GROWTH-FACTOR STIMULATES MOTOR AND SENSORY AXON REGENERATION AFTER SCIATIC-NERVE CRUSH IN THE RAT

      Neuroscience
    40. GILL R; HARGREAVES RJ; KEMP JA
      THE NEUROPROTECTIVE EFFECT OF THE GLYCINE SITE ANTAGONIST 3R-(-CIS-4-METHYL-HA966 (L-687,414) IN A RAT MODEL OF FOCAL ISCHEMIA())

      Journal of cerebral blood flow and metabolism
    41. TAN KKC; BROWN MJ; HARGREAVES RJ; SHEPHERD SL; COOK DA; HILL RG
      CALCITONIN-GENE-RELATED PEPTIDE AS AN ENDOGENOUS VASODILATOR - IMMUNOBLOCKADE STUDIES IN-VIVO WITH AN ANTI-CALCITONIN GENE-RELATED PEPTIDE MONOCLONAL-ANTIBODY AND ITS FAB-'-FRAGMENT

      Clinical science
    42. SHEPHEARD SL; WILLIAMSON DJ; WILLIAMS J; HILL RG; HARGREAVES RJ
      COMPARISON OF THE EFFECTS OF SUMATRIPTAN AND THE NK1 ANTAGONIST CP-99,994 ON PLASMA EXTRAVASATION IN DURA-MATER AND C-FOS MESSENGER-RNA EXPRESSION IN TRIGEMINAL NUCLEUS CAUDALIS OF RATS

      Neuropharmacology
    43. TATTERSALL FD; RYCROFT W; MARMONT N; CASCIERI M; HILL RG; HARGREAVES RJ
      ENANTIOSPECIFIC INHIBITION OF EMESIS INDUCED BY NICOTINE IN THE HOUSEMUSK SHREW (SUNCUS-MURINUS) BY THE NEUROKININ(1) (NK1) RECEPTOR ANTAGONIST CP-99,994

      Neuropharmacology
    44. STREET LJ; BAKER R; DAVEY WB; GUIBLIN AR; JELLEY RA; REEVE AJ; ROUTLEDGE H; STERNFELD F; WATT AP; BEER MS; MIDDLEMISS DN; NOBLE AJ; STANTON JA; SCHOLEY K; HARGREAVES RJ; SOHAL B; GRAHAM MI; MATASSA VG
      SYNTHESIS AND SEROTONERGIC ACTIVITY OF HYL-2-[5-(1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOL-3-YL] ETHYLAMINE AND ANALOGS - POTENT AGONISTS FOR 5-HT1D RECEPTORS

      Journal of medicinal chemistry
    45. TATTERSALL FD; RYCROFT W; HILL RG; HARGREAVES RJ
      ENANTIOSELECTIVE INHIBITION OF APOMORPHINE-INDUCED EMESIS IN THE FERRET BY THE NEUROKININ(1) RECEPTOR ANTAGONIST CP-99,994

      Neuropharmacology
    46. PATEL S; SMITH AJ; CHAPMAN KL; FLETCHER AE; KEMP JA; MARSHALL GR; HARGREAVES RJ; RYECROFT W; IVERSEN LL; IVERSEN SD; BAKER R; SHOWELL GA; BOURRAIN S; NEDUVELIL JG; MATASSA VG; FREEDMAN SB
      BIOLOGICAL PROPERTIES OF THE BENZODIAZEPINE AMIDINE DERIVATIVE L-740,093, A CHOLECYSTOKININ-B GASTRIN RECEPTOR ANTAGONIST WITH HIGH-AFFINITY IN-VITRO AND HIGH POTENCY IN-VIVO

      Molecular pharmacology
    47. LAIRD JMA; MASON GS; THOMAS KA; HARGREAVES RJ; HILL RG
      ACIDIC FIBROBLAST GROWTH-FACTOR (AFGF) STIMULATES RAT SCIATIC-NERVE REGENERATION AFTER A CRUSH INJURY

      Journal of physiology
    48. CASTRO JL; BAKER R; GUIBLIN AR; HOBBS SC; JENKINS MR; RUSSELL MGN; BEER MS; STANTON JA; SCHOLEY K; HARGREAVES RJ; GRAHAM MI; MATASSA VG
      SYNTHESIS AND BIOLOGICAL-ACTIVITY OF ETHYL-1,2,5-THIADIAZOLIDIN-2-YL)-METHYL]-1H-INDOLE AND ANALOGS - AGONISTS FOR THE 5-HT1D RECEPTOR

      Journal of medicinal chemistry
    49. TAN KKC; BROWN MJ; HARGREAVES RJ; SHEPHEARD SL; COOK DA; HILL RG
      CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AS AN ENDOGENOUS VASODILATOR -IN-VIVO IMMUNOBLOCKADES STUDIES WITH AN ANTI-CGRP MONOCLONAL-ANTIBODYAND ITS FAB' FRAGMENT

      British Journal of Pharmacology
    50. HARGREAVES RJ; HILL RG; IVERSEN LL
      NEUROPROTECTIVE NMDA ANTAGONISTS - THE CONTROVERSY OVER THEIR POTENTIAL FOR ADVERSE-EFFECTS ON CORTICAL NEURONAL MORPHOLOGY

      Acta neurochirurgica
    51. HARGREAVES RJ; RIGBY M; SMITH D; HILL RG; IVERSEN LL
      COMPETITIVE AS WELL AS UNCOMPETITIVE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS AFFECT CORTICAL NEURONAL MORPHOLOGY AND CEREBRAL GLUCOSE-METABOLISM

      Neurochemical research
    52. STREET LJ; BAKER R; CASTRO JL; CHAMBERS MS; GUIBLIN AR; HOBBS SC; MATASSA VG; REEVE AJ; BEER MS; MIDDLEMISS DN; NOBLE AJ; STANTON JA; SCHOLEY K; HARGREAVES RJ
      SYNTHESIS AND SEROTONERGIC ACTIVITY OF 5-(OXADIAZOLYL)TRYPTAMINES - POTENT AGONISTS FOR 5-HT(1D) RECEPTORS

      Journal of medicinal chemistry
    53. TATTERSALL FD; RYCROFT W; HARGREAVES RJ; HILL RG
      THE TACHYKININ NK(1) RECEPTOR ANTAGONIST CP-99,994 ATTENUATES CISPLATIN-INDUCED EMESIS IN THE FERRET

      European journal of pharmacology
    54. BEER MS; STANTON JA; BEVAN Y; HEALD A; REEVE AJ; STREET LJ; MATASSA VG; HARGREAVES RJ; MIDDLEMISS DN
      L-694,247 - A POTENT 5-HT(1D) RECEPTOR AGONIST

      British Journal of Pharmacology
    55. HARGREAVES RJ; RIGBY M; SMITH D; HILL RG
      LACK OF EFFECT OF L-687,414 ((-CIS-4-METHYL-HA-966), AN NMDA RECEPTORANTAGONIST ACTING AT THE GLYCINE SITE, ON CEREBRAL GLUCOSE-METABOLISMAND CORTICAL NEURONAL MORPHOLOGY())

      British Journal of Pharmacology
    56. LAIRD JMA; HARGREAVES RJ; HILL RG
      EFFECT OF RP 67580, A NONPEPTIDE NEUROKININ(1) RECEPTOR ANTAGONIST, ON FACILITATION OF A NOCICEPTIVE SPINAL FLEXION REFLEX IN THE RAT

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 03:29:40